20105 results for «»
20105 results
#PCRLV 2023 Social Media Team
Mechanical circulatory support in cardiogenic shock: should it become routine?
12 Sep 2024
Discover the current use of mechanical circulatory support in patients with myocardial infarction and cardiogenic shock.
Contribute to PCR-CIT China Chengdu Valves
23 Jul 2024
PCR Tricuspid Focus Group - referral meeting in Kiel
26 Jul 2024
Join your peers for this meeting on 11 October 2024 in Kiel, Germany!
Matthias Petersen
Kiel, Germany
Johanne Frank
Kiel, Germany
EuroPCR 2024 delivered an eye-opening focus on imaging guidance
24 May 2024
A record 12,100 participants from 130 countries have just taken part in the highly educational WorldLeading Course in interventional cardiovascular medicine. They enjoyed a unique opportunity to exchange their knowledge, skills and experience on a global scale.
Paris – France, 17 May 2024. As always, the thought-provoking...
PCR Webinars: Bringing the hot topics in interventional cardiology to your home
10 Jun 2024
According to Medical Director of PCR Webinars, Dejan Milasinovic, two novel additions to the platform will increase the interactive experience and take webinar based learning to a new level.
A journey through tricuspid regurgitation phenotypes
28 May 2024
Watch the replay of this webinar to learn about secondary tricuspid regurgitation (TR) and management of TR in patients with cardiac implantable electronic devices (CIED) and much more!
TAVI for today and tomorrow - What matters the most to patients?
28 May 2024
Watch the replay of this webinar with R. Hahn, K. Hayashida, M. Joner and S. Redwood on how to illustrate how TAVI would optimise the full spectrum of lifetime management to all patients and much more!
Influence of pathophysiological patterns of coronary artery disease on immediate percutaneous coronary intervention outcomes
28 May 2024
This study demonstrated, for the first time, that PPG - an index to characterize focal vs. diffuse disease - can predict optimal functional revascularization outcomes (post-PCI FFR ≥ 0.88) more accurately than FFR alone.
Reviewer
Reviewer
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.
Author
A review of the 2024 ESC Guidelines on elevated blood pressure and hypertension
13 Nov 2024
Lucas Lauder and Felix Mahfoud provide a summary of the ESC Guidelines on elevated blood pressure and hypertension presented by John William McEvoy and Rhian Touyz at ESC Congress 2024 in London.
Author
Author
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes
03 Jun 2024
The optimal duration of short DAPT in ACS patients is unknown, therefore this analysis of the XIENCE Short DAPT programme compared the clinical outcomes of one versus three months DAPT in HBR patients with and without ACS.
Reviewer
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area
03 Jun 2024
This pre-specified substudy of CompareCrush aimed to examine if patients with a large myocardial infarction benefit from prehospital crushed prasugrel.
Reviewer
Charles Fauvel
Rouen, France
Attend Alfieri's Bootcamp: map, visas & letter of invitation!
Flat-out success: TAVI in a patient with a horizontal aorta and large annulus
16 Oct 2024
Study the case of an 86-year-old male patient with progressive NYHA III dyspnoea, HTN, AF and previous stroke who presented with HF, LVEF 61 %, severe atrial dilatation, severe AS, mild MR and severely calcified tricuspid aortic valve with a large annulus suitable for transfemoral TAVI.
Author
Author
Alfieri's Bootcamp – Programme
